GlaxoSmithKline PLC to Discuss RSV Vaccines Data Investor Call Transcript
Good day, everyone, and welcome to GSK's RSV investor call. My name is Deborah, and I'm your event manager. (Operator Instructions) I would like to advise all parties the conference is being recorded.
And now initially, I will hand on to Sarah Elton-Farr, Global Head of Investor Relations. Sarah, please go ahead. Thank you.
Thank you, Deborah. Good morning and good afternoon. Thank you for joining us to discuss the data presented at ID Week on our RSV vaccine candidates for older adults and maternal immunization. You can access the slides we are going to use in this presentation on the Investors section of GSK's website under Speeches and Presentations.
I would ask you to please review our cautionary statements on Page 2. Also, please note that as we are in close period in our Q3 results next week, we will not be answering any questions on the performance of the business.
And now I'll hand over to Dr. Hal Barron, Chief Scientific Officer and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
